Clinical Trial Update: BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for an inhaled budesonide/formoterol product in asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide 80 μg / Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product

Snippet

Sponsor: Cipla Ltd. | Conditions: Asthma | Phase 3 | Status: COMPLETED